![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Blood Cell Indices and Neurocognitive Impairment in the HAART Era: A CHARTER Study
|
|
|
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
Asha Kallianpur1, Quan Wang2, Peilin Jia2, Todd Hulgan2, Zhongming Zhao2, Scott Letendre3, Ronald Ellis3, Robert Heaton3, Donald Franklin3, Jill Barnholtz-Sloan4, Ann Collier5, Christina Marra5, David Clifford6, Benjamin Gelman7, Justin McArthur8, Susan Morgello9, David Simpson9, J. Allen McCutchan3, and Igor Grant3 for the CHARTER Study Group. 1Cleveland Clinic Foundation/Lerner Research Institute, Cleveland, OH; 2Vanderbilt University School of Medicine, Nashville, TN; 3University of California, San Diego, CA , 4Case Western Reserve University, Cleveland, OH; 5University of Washington, Seattle, WA; 6Washington University School of Medicine, St. Louis, MO; 7University of Texas Medical Branch, Galveston, TX; 8Johns Hopkins University School of Medicine, Baltimore, MD; 9Icahn School of Medicine of Mount Sinai, New York, NY.
![CROI1.gif](../images/031914/031914-10/CROI1.gif)
![CROI2.gif](../images/031914/031914-10/CROI2.gif)
![CROI3.gif](../images/031914/031914-10/CROI3.gif)
![CROI4.gif](../images/031914/031914-10/CROI4.gif)
![CROI5.gif](../images/031914/031914-10/CROI5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|